Method of treating prader-willi syndrome
作者： Pascal Danglas , Michael Reidy , Paul Korner , Sudarkodi Alagarsamy
DOI:
关键词:
摘要: This disclosure relates to a method of treating Prader-Willi Syndrome. The includes administering patient in need thereof an effective amount composition containing selective oxytocin receptor agonist or pharmaceutically acceptable salt thereof.
lens.org 参考文章(33)
M MANNING, S STOEV, B CHINI, T DURROUX, B MOUILLAC, G GUILLON, Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Progress in Brain Research. ,vol. 170, pp. 473- 512 ,(2008) , 10.1016/S0079-6123(08)00437-8
Claudio Daniel Schteingart, Kazimierz A. Wisniewski, Sudarkodi Alagarsamy, Robert Galyean, Oxytocin receptor agonists ,(2010)
Ralph A. Nelson, James D. Shoemaker, Polypeptides useful for appetite suppression ,(2006)
Paul J Sheskey, Marian E Quinn, Raymond C Rowe, Handbook of Pharmaceutical Excipients ,(1994)
Larry James Young, Meera E. Modi, Methods of improving behavioral therapies ,(2013)
Joan Busner, Steven D Targum, The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont (Pa. : Township)). ,vol. 4, pp. 28- 37 ,(2007)
Henry R. Costantino, Anthony P. Sileno, Joshua O. Sestak, Alexis Kays Leonard, Kayvon Emile Sharghi, Garland M. Bellamy, Jason Philip Gesty, Lalit Raj Peddakota, Intranasal carbetocin formulations and methods for the treatment of autism ,(2007)
Christophe Grundschober, Konrad Bleicher, Caterina Bissantz, Peptides as oxytocin agonists ,(2015)
Françoise Muscatelli, Denise Thuilleaux, Maithé Tauber, Fabienne Schaller, Methods and Pharmaceutical Composition for the Treatment of a Feeding Disorder with Early-Onset in a Patient ,(2011)